Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.
about
Antigenic variability: Obstacles on the road to vaccines against traditionally difficult targets.Identification of shared TCR sequences from T cells in human breast cancer using emulsion RT-PCRMolecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model.Structural basis for ineffective T-cell responses to MHC anchor residue-improved "heteroclitic" peptides.
P2860
Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Improving antigenic peptide va ...... umor-specific T cell receptor.
@ast
Improving antigenic peptide va ...... umor-specific T cell receptor.
@en
type
label
Improving antigenic peptide va ...... umor-specific T cell receptor.
@ast
Improving antigenic peptide va ...... umor-specific T cell receptor.
@en
prefLabel
Improving antigenic peptide va ...... umor-specific T cell receptor.
@ast
Improving antigenic peptide va ...... umor-specific T cell receptor.
@en
P2093
P2860
P356
P1476
Improving antigenic peptide va ...... umor-specific T cell receptor.
@en
P2093
Brandon L Moore
Daniel J Munson
Jill E Slansky
Jonathan D Buhrman
Kimberly R Jordan
P2860
P304
33213-33225
P356
10.1074/JBC.M113.509554
P407
P50
P577
2013-10-08T00:00:00Z